A welsh 2010

2010 has seen me spend the majority of the year at Penn Pharmaceuticals, an SME with about 280 lovely people. Along with all of the normal challenges we faced and worked our way successfully through both FDA and MHRA scheduled audits. I was appointed Interim Chief Operating Officer, and also had the enjoyable task of finding my successor, David Cooper, who I wish every success.

Penn is a complex site near Tredegar and holds all of the MHRA Licenses. Providing a Contract Development and Manufacturing Service to companies around the world, I recommend a visit to its website (click on the title above).